Most of the genetic covariation between major depressive and alcohol use disorders is explained by trait measures of negative emotionality and behavioral control by Ellingson, J. M et al.




Most of the genetic covariation between major
depressive and alcohol use disorders is explained by
trait measures of negative emotionality and
behavioral control
J. M. Ellingson
Washington University School of Medicine in St. Louis
L. S. Richmond-Rakerd
Washington University School of Medicine in St. Louis
D. J. Statham
University of the Sunshine Coast
N. G. Martin
QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Austrailia
W. S. Slutske
Washington University School of Medicine in St. Louis
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Ellingson, J. M.; Richmond-Rakerd, L. S.; Statham, D. J.; Martin, N. G.; and Slutske, W. S., ,"Most of the genetic covariation between
major depressive and alcohol use disorders is explained by trait measures of negative emotionality and behavioral control."
Psychological Medicine.2016,July. 1-12. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5225
Most of the genetic covariation between major
depressive and alcohol use disorders is explained
by trait measures of negative emotionality and
behavioral control
J. M. Ellingson1,2*, L. S. Richmond-Rakerd1,2, D. J. Statham3, N. G. Martin4 and W. S. Slutske1,2
1Department of Psychological Sciences, University of Missouri, Columbia, MO, USA
2Alcoholism Research Center at Washington University School of Medicine, St Louis, MO, USA
3University of the Sunshine Coast, Queensland, Australia
4Genetic Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Background. Mental health disorders commonly co-occur, even between conceptually distinct syndromes, such as in-
ternalizing and externalizing disorders. The current study investigated whether phenotypic, genetic, and environmental
variance in negative emotionality and behavioral control account for the covariation between major depressive disorder
(MDD) and alcohol use disorder (AUD).
Method. A total of 3623 members of a national twin registry were administered structured diagnostic telephone inter-
views that included assessments of lifetime histories of MDD and AUD, and were mailed self-report personality ques-
tionnaires that assessed stress reactivity (SR) and behavioral control (CON). A series of biometric models were ﬁtted to
partition the proportion of covariance between MDD and AUD into SR and CON.
Results. A statistically signiﬁcant proportion of the correlation between MDD and AUD was due to variance speciﬁc to
SR (men = 0.31, women = 0.27) and CON (men = 0.20, women = 0.19). Further, genetic factors explained a large proportion
of this correlation (0.63), with unique environmental factors explaining the rest. SR explained a signiﬁcant proportion of
the genetic (0.33) and environmental (0.23) overlap between MDD and AUD. In contrast, variance speciﬁc to CON
accounted for genetic overlap (0.32), but not environmental overlap (0.004). In total, SR and CON accounted for approxi-
mately 70% of the genetic and 20% of the environmental covariation between MDD and AUD.
Conclusions. This is the ﬁrst study to demonstrate that negative emotionality and behavioral control confer risk for the
co-occurrence of MDD and AUD via genetic factors. These ﬁndings are consistent with the aims of NIMH’s RDoC pro-
posal to elucidate how transdiagnostic risk factors drive psychopathology.
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Introduction
Co-occurring mental health disorders are common.
Epidemiological studies estimate that 17% of US adults
meet past-year criteria for multiple diagnoses, repre-
senting half of those with any psychiatric disorder
(Kessler et al. 2005). Even conceptually distinct disor-
ders frequently co-occur, such as internalizing (e.g.
related to anxiety, mood) and externalizing (e.g.
related to substance use, impulse control) disorders.
For example, individuals with a past-year alcohol use
disorder (AUD), relative to those without, are 2.3
times more likely to meet criteria for major depressive
disorder (MDD; Grant et al. 2004). Further, individuals
with multiple mental health diagnoses receive more
treatment but have greater disability after treatment
than those with one diagnosis (Burns et al. 2005).
Therefore, understanding the common mechanisms
underlying diverse forms of psychopathology is of
great public health importance. The current study
investigated whether phenotypic and genetic variance
in negative emotionality and behavioral control ac-
count for the covariation between two conceptually
distinct disorders: MDD and AUD.
Factor analytic work has consistently demonstrated
that internalizing and externalizing factors capture a
large degree of covariation among common mental
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health disorders (see Krueger & Markon, 2006 for a re-
view). A similar two-factor model also ﬁts genetic co-
variation among mental health disorders (Kendler
et al. 2011). These two distinct classes of psychopath-
ology have been consistently identiﬁed across research
groups, samples, and analytic approaches. It is often
overlooked, however, that these two factors demon-
strate moderate phenotypic (r = 0.41–0.66; Gjone &
Stevenson, 1997; Lahey et al. 2004; Krueger &
Markon, 2006; Lahey et al. 2012) and genetic (rG =
0.52–0.53; Kendler & Myers, 2014) correlation, suggest-
ing that common risk processes may be involved in
both. Focusing on transdiagnostic risk factors, includ-
ing personality and genetic factors, is consistent with
the aim of NIMH’s Research Domain Criteria (RDoC)
Project to identify fundamental risk factors that span
multiple disorders (Insel et al. 2010; Sanislow et al.
2010). Identifying these common risk factors is pert-
inent to improving etiologic models of how distinct
disorders co-occur, as well as their diagnostic classiﬁ-
cation and criteria. Further, such risk factors may in-
form intervention efforts aimed at more effectively
addressing co-occurring problems.
Empirical work on the internalizing and externaliz-
ing disorders suggests at least two mechanisms that
may underlie their co-occurrence. First, negative emo-
tionality, or general distress, is often linked to internal-
izing psychopathology (Andrews et al. 1990; Clark &
Watson, 1991). For example, neuroticism loads onto
an internalizing spectrum factor (Hettema et al. 2006;
Eaton et al. 2011), and it has substantial genetic overlap
with major depression (rG = 0.49–0.67; Fanous et al.
2002). Further, neuroticism is correlated with substance
use disorders (Malouff et al. 2007), and affect regula-
tion models suggest that individuals high in trait
neuroticism may use alcohol to regulate emotions
(Cooper et al. 1995). In addition to being associated
with internalizing and externalizing disorders, nega-
tive emotionality explains a substantial proportion of
the phenotypic covariation among these disorders
(Khan et al. 2005; Ellingson et al. 2015). Notably, this
risk factor resembles the negative valence system,
highlighted in the RDoC proposal, which includes sub-
constructs related to anxiety (e.g. potential threat) and
sadness (e.g. loss).
Second, theoretical work suggests that trait disinhib-
ition, deﬁned as behavior ‘arising from lessened con-
trols on response inclinations’, broadly confers risk
for externalizing disorders (Gorenstein & Newman,
1980, p. 302, Sher & Trull, 1994; Nigg, 2003).
Speciﬁcally, disinhibition is attributable to an imbal-
ance between reward sensitivity and behavioral
(under)control, resulting in greater consideration
being given to proximal outcomes (e.g. getting
drunk/high) over more distal outcomes (e.g. social or
occupational goals). Reward sensitivity maps onto ap-
petitive motivation (e.g. for getting drunk/high; Gray,
1990) and may be speciﬁc to externalizing disorders.
In contrast, behavioral undercontrol maps onto execu-
tive functioning (Miyake et al. 2000), or executive con-
trol (Nigg, 2003), and appears to more broadly
underlie psychopathology.
Behavioral control (reverse-scored) loads onto an
externalizing spectrum factor and is related to
phenotypic and genetic liability for externalizing
psychopathology (Krueger et al. 2002). Similarly, con-
trol-based risk factors appear to be involved in intern-
alizing disorders, with conscientiousness being the
second-strongest personality correlate of MDD, after
neuroticism (Kendler & Myers, 2010). The parallels be-
tween conscientiousness and behavioral control have
been highlighted in the impulsivity literature, with
both loading onto the construct of lack of planning
(Whiteside & Lynam, 2001). Therefore, the deﬁnition
of behavioral control in the current study was adapted
from Whiteside & Lynam’s (2001) deﬁnition of lack of
planning (the tendency to act on the spur of the mo-
ment and at the cost of long-term goals). Empirical
work suggests mechanisms by which behavioral con-
trol may underlie both MDD and AUD, including at-
tentional biases (Hankin et al. 2010; Sharbanee et al.
2014), delay discounting (Bickel & Marsch, 2001;
Pulcu et al. 2014), and effortful/inhibitory control
(Field et al. 2010; Kanske & Kotz, 2012). Consistent
with this literature, prior work by our group has
shown that trait effortful control (comprised of atten-
tional, activational, and inhibitory control) explains
phenotypic covariation between MDD and AUD, be-
yond what can be explained by negative emotionality
(Ellingson et al. 2015). Further, behavioral control ﬁts
within the RDoC cognitive system, which includes
constructs related to attention, response selection,
and response inhibition.
The present study aimed to extend these ﬁndings
using a national sample of adult twins. First, we
attempted to replicate work showing that trait mea-
sures of negative emotionality and behavioral control
account for unique covariation between MDD and
AUD (Ellingson et al. 2015). Second, behavior genetic
models were used to investigate whether negative
emotionality and behavioral control account for the
genetic covariation between MDD and AUD. Given
that no prior research has investigated the role of
these personality measures in explaining the genetic
covariation between internalizing and externalizing
psychopathology, these analyses were largely explora-
tory. We proposed three hypotheses for these models.
First, we hypothesized that genetic factors would com-
prise most of the phenotypic covariation between
MDD and AUD, as is typically the case for phenotypic
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covariance among disorders (e.g. Krueger et al. 2002;
Kendler et al. 2011). Second, given the large body of
evidence implicating negative emotionality as a risk
factor for internalizing and externalizing disorders
(e.g. Khan et al. 2005; Tackett et al. 2013), we expected
that it would explain a signiﬁcant proportion of the co-
variation among MDD and AUD. Finally, mounting
evidence suggests that behavioral control is involved
in risk for internalizing and externalizing psychopath-
ology (e.g. Field et al. 2010; Kanske & Kotz, 2012), and
we hypothesized that it would explain some degree of
covariance, beyond what is accounted for by negative
emotionality. The degree to which these factors ac-
count for covariation among these conceptually dis-
tinct disorders will help determine the extent to




Participants were 3623 members of the Australian
Twin Registry (ATR) Cohort II. In 1980–1982, a sample
of 4268 twin pairs born during 1964–1971 were regis-
tered with the ATR, in response to appeals though
the media and Australian school systems. They were
ﬁrst surveyed in 1989–1992. Data in the current study
were collected in 2004–2007, for a study primarily fo-
cused on gambling (Slutske et al. 2009), via structured
diagnostic telephone interview and mailed self-report
questionnaire [interview: n = 4764 twins, mean age =
37.7 years (range = 32–43), response rate = 80%; ques-
tionnaire: n = 4369 twins, response rate = 92%]. The cur-
rent study was based on data from same-sex
monozygotic (MZ) and dizygotic (DZ) twins. There
were 1461 complete twin pairs [867 MZ (347 male,
520 female), 594 DZ (227 male, 367 female)] and 701
twins from incomplete pairs [304 MZ (153 male, 151 fe-
male), 397 DZ (216 male, 181 female)].
Procedures
Interviews were conducted by trained lay-interviewers
who were blind to the psychiatric status (e.g. diagno-
ses) of the co-twin. Informed consent was obtained
from all participants.
Retest data were collected for a small subsample of
the participants (n = 166) several months after their ini-
tial interview [mean interval = 3.4 months (standard
deviation (S.D.) = 1.4 months, range = 1.2–9.5 months].
These data were used to evaluate the test-retest reliabil-
ity of the diagnostic measures, using the kappa (κ)




Participants who completed the diagnostic interview
were also administered the 196-item Multidimensional
Personality Questionnaire (MPQ; Tellegen, 1982), a Big
Three measure of personality. The MPQ consists of
three higher-order scales that are each composed of
3–4 lower-order subscales: Constraint (Control, Trad-
itionalism, and Harm Avoidance), Negative Emotion-
ality (Stress Reaction, Alienation, and Aggression),
and Positive Emotionality (Wellbeing, Social Potency,
Social Closeness, and Achievement). The current
study used the 14-item Stress Reaction subscale (SR;
e.g. ‘I am too sensitive for my own good’) and the
20-item Control subscale (CON; e.g. ‘I often act with-
out thinking’). As a subscale of negative emotionality,
SR correlates strongly with other indicators of the ten-
dency to experience negative affective states, such as
Neuroticism from the NEO Five-Factor Inventory
(NEO-FFI; McCrae & Costa, 1987) (r = 0.73; Tellegen
& Waller, 2008). In contrast, the CON subscale was
developed to assess self-regulation and correlates mod-
erately with Conscientiousness from the NEO-FFI (r =
0.52). Adequate internal consistency was demonstrated
for both SR (α = 0.86) and CON (α = 0.81) in the current
sample.
AUD
The AUD section from the WHO Composite
International Diagnostic Interview (CIDI) was used to
assess lifetime AUD symptoms (Robins et al. 1988).
These symptoms were used to create an approximate
DSM-5 AUD diagnosis based on a cut-off of endorsing
two or more symptoms (excluding ‘craving,’ which
was not included in this version of the CIDI). About
one-third of participants met criteria for AUD
(30.5%). The estimated test–retest reliability for this
measure of AUD was 0.57 based on κ [95% conﬁdence
interval (CI) 0.42–0.71] and 0.63 based on Y (95% CI
0.47–0.79).
MDD
The assessment of MDD was a modiﬁed version of the
depression assessment from the Alcohol Use Disorder
and Associated Disabilities Interview Schedule – IV
used in the National Epidemiologic Survey of
Alcohol and Related Conditions (Grant et al. 2004).
To be administered all MDD criteria, individuals had
to endorse having experienced a period of at least 2
weeks during which depressed mood or loss of inter-
est/pleasure in daily activities was present. These
symptoms were used to create a DSM-5 MDD diagno-
sis based on a cut-off of endorsing ﬁve or more
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symptoms. Distress, impairment, and exclusionary cri-
teria (e.g. depression due to physical causes) were not
assessed, resulting in a broad diagnosis of MDD.
About one-third of participants met criteria for MDD
(33.0%), and the estimated test–retest reliability was
0.71 based on κ (95% CI 0.59–0.84) and 0.73 based on
Y (95% CI 0.60–0.85).
Statistical analyses
A series of biometric models was ﬁtted directly to the
raw twin data by the method of robust weighted least
squares (for the analysis of categorical phenotypes) or
maximum likelihood (for the analysis of continuous
phenotypes) using the Mplus program version 7
(Muthén & Muthén, 1998–2012). To account for miss-
ing data, including incomplete twin pairs, analyses
were conducted using full information maximum like-
lihood (FIML; Enders & Bandalos, 2001). Models were
iteratively ﬁt to all phenotypes to determine the
best-ﬁtting reduced models to carry forward for the
ﬁnal parameter estimates. As described below, vari-
ance due to the shared family environment was negli-
gible in univariate models (i.e. for each phenotype) and
in a quadrivariate model (i.e. including all pheno-
types), resulting in reduced models estimating only
genetic and unique environmental contributions.
Bivariate model ﬁtting was conducted with (1) MDD
and CON, (2) MDD and SR, (3) AUD and CON, and
(4) AUD and SR, in order to partition the covariation
between each pair of variables into genetic and envir-
onmental factors.
Fig. 1 depicts one of two quadrivariate Cholesky
models (Neale & Cardon, 1992; Loehlin, 1996) that
were ﬁtted to quantify the extent to which (a) the
phenotypic covariation between MDD and AUD was
explained by SR and CON, and (b) the genetic and en-
vironmental covariation between MDD and AUD was
explained by additive genetic and unique environmen-
tal factors due to SR and CON. In this ﬁrst model, fac-
tor A1 accounts for all of the genetic variation in SR
(the variable entered ﬁrst) and the genetic variation
in CON (path a12), AUD (a13), and MDD (a14) that
is explained by SR. Factor A2 then accounts for the re-
sidual genetic variation (i.e. after accounting for vari-
ation in SR) in CON (a22), and any residual genetic
variation in AUD (a23) and MDD (a24) that is due to
CON. Factor A3 accounts for any residual genetic vari-
ation (i.e. after accounting for variation in SR and
CON) in AUD (a33), and any residual genetic variation
in MDD (a34) due to AUD. Finally, factor A4 accounts
for any genetic variation in the risk for MDD, unex-
plained by SR, CON, and AUD. This same approach
was applied to decompose the unique environmental
variation using factors E1, E2, E3, and E4.
The total genetic covariation between MDD and
AUD is the sum of pathways (a13 × a14), (a23 × a24),
and (a33 × a34). The proportion of genetic covariation
between MDD and AUD that is attributable to CON
(after accounting for genetic variation shared with
SR) is [(a23 × a24)/(a13 × a14 + a23 × a24 + a33 × a34)]
and the covariation not explained by CON or SR is
[(a33 × a34)/(a13 × a14 + a23 × a24 + a33 × a34)]. The pro-
portion of phenotypic covariation between MDD and
AUD that is explained by variance speciﬁc to CON is
[(a23 × a24) + (e23 × e24)/(a13 × a14 + a23 × a24 + a33 × a34)
+ (e13 × e14 + e23 × e24 + e33e34)]. To determine the pro-
portion of phenotypic, genetic, and environmental co-
variation that was unique to SR (i.e. after accounting
for CON), the quadrivariate model was re-run with
CON entered ﬁrst and SR entered second. Therefore,
the quadrivariate models estimated the proportion of
phenotypic, genetic, and environmental covariation be-
tween MDD and AUD due to (1) SR only, (2) CON
only, (3) both SR and CON, and (4) neither SR nor CON.
Ethical standards
The authors assert that all procedures contributing to
this work comply with the ethical standards of the rele-
vant national and institutional committees on human
experimentation and with the Helsinki Declaration of
1975, as revised in 2008. The Institutional Review
Board at the University of Missouri and the Human
Research Ethics Committee at the Queensland




Phenotypic correlations were estimated using PROC
CORR in SAS version 9.4 (SAS Institute, 2002–2010; see
Table 1). Subsequently, phenotypic structural equation
models (similar to the biometric models) were ﬁtted to
determine the proportions of covariance between
MDD and AUD that were attributable to SR and
CON. Estimates from the quadrivariate model sug-
gested that MDD and AUD were comparably corre-
lated among men (r = 0.34, 95% CI 0.20–0.48) and
women [r = 0.32, 95% CI 0.22–0.42)]†1. The correlation
between SR and CON was higher among men
[0.14 (0.08–0.19)] than women [0.06 (0.01–0.10)]. Among
men, a statistically signiﬁcant proportion of the correl-
ation between MDD and AUD was accounted for by
variance speciﬁc to SR [0.31 (0.18–0.44)] and CON
† The notes appear after the main text.
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[0.20 (0.07–0.33)]. Similar estimates were obtained
among women [SR = 0.27 (0.14–0.40); CON = 0.19
(0.06–0.33)]. Therefore, there was evidence that CON
explains unique covariation between MDD and AUD,
above what is explained by SR. A small proportion
of the correlation was also due to variance common
to SR and CON. In total, variance unique to and shared
by SR and CON explained approximately half of the
phenotypic correlation between MDD and AUD.
Biometric analyses were conducted to determine the
degree to which this covariation was explained by gen-
etic and/or environmental inﬂuences on SR and CON.
Twin correlations
Table 2 displays the within-trait and cross-trait twin
correlations. Inspection reveals that the within-trait
MZ correlations were larger than the DZ correlations
for MDD, AUD, SR, and CON, which implicates genet-
ic inﬂuences for all of the phenotypes studied. In add-
ition, the cross-trait MZ correlations were larger than
the DZ correlations for MDD, AUD, SR, and CON,
which implicates genetic inﬂuences on the covariation
between these traits.
Biometric model ﬁtting
Results from the bivariate biometric models are dis-
played in Table 3. These models ﬁt very well (root
mean square error of approximation <0.02). Notably,
additive genetic factors explained nearly all of the co-
variation between CON and AUD (0.96) and a sub-
stantial proportion of the covariation between CON
and MDD (0.83). Genetic contributions to the covari-
ation between SR and the two disorders were less sub-
stantial (AUD: proportion A = 0.56, MDD: proportion
Fig. 1. A model quantifying the extent to which the genetic and environmental covariation between major depressive
disorder (MDD) and alcohol use disorder (AUD) is explained by (1) additive genetic and unique environmental factors that
inﬂuence stress reaction (SR), (2) additive genetic and unique environmental factors that inﬂuence behavioral control (CON),
and (3) additive genetic and unique environmental factors that inﬂuence both SR and CON. For simplicity, this model is
illustrated for only one individual from a twin pair. In this model, SR is entered ﬁrst; thus, the proportion of genetic
covariation between MDD and AUD that is attributable to CON (after accounting for genetic variation shared with SR) is
[(a23 × a24)/(a13 × a14 + a23 × a24 + a33 × a34)]. To determine the proportion of genetic covariation attributable to SR (after
accounting for genetic variation shared with CON), this model was re-run with CON entered ﬁrst.
Table 1. Phenotypic correlations between major depressive
disorder, alcohol use disorder, stress reaction, and behavioral control
Phenotype 1 2 3 4
1. Major depressive disorder – 0.31 0.39 0.08
2. Alcohol use disorder 0.33 – 0.20 0.29
3. Stress reaction 0.42 0.24 – 0.06
4. Behavioral control 0.13 0.22 0.14 –
Estimates for men are on the lower diagonal, women on
the upper diagonal.
Correlations between major depressive disorder (MDD)
and alcohol use disorder (AUD) are tetrachoric coefﬁcients.
Correlations between MDD and stress reaction (SR), MDD
and behavioral control (CON), AUD and SR, and AUD and
CON are biserial coefﬁcients. Correlations between SR and
CON are Pearson coefﬁcients.
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A = 0.59). Genetic and environmental correlations were
also estimated between the psychiatric and personality
measures. Whereas SR demonstrated genetic and en-
vironmental overlap with psychiatric outcomes, CON
demonstrated only genetic overlap.
A quadrivariate biometric model was constructed to
decompose the genetic and environmental covariance
between AUD and MDD into CON and SR (see
Supplementary material for model-ﬁtting results). An
initial model included all three biometric factors
(ACE), and a nested model ﬁxed variance due to C
at zero without a signiﬁcant decrement in ﬁt. Given
the negligible inﬂuence of C, AE models were carried
forward. We ﬁrst ﬁt an AE model in which SR was
entered ﬁrst, in order to derive genetic and environ-
mental estimates speciﬁc to CON. Within this model,
constraining parameters to be the same across men
and women did not provide a signiﬁcant decrement
in ﬁt, suggesting that there were no sex differences in
the sources of covariation between MDD and AUD
(see Supplementary material). The phenotypic correl-
ation between MDD and AUD in the constrained
model was 0.33, of which approximately two-thirds
was explained by genetic inﬂuences [A = 0.63 (0.41–
0.85)] and one-third was explained by unique environ-
mental inﬂuences [E = 0.37 (0.15–0.59)].
The standardized estimate for the genetic parameter
from SR to CON (path a12) was low and non-
signiﬁcant [0.002 (−0.01 to 0.02)], and constraining it
to zero did not signiﬁcantly worsen model ﬁt.
Further, after accounting for SR, the proportion of
environmental covariance explained by environmental
inﬂuences on CON [(e23 × e24)/(e13 × e14 + e23 × e24 +
e33 × e34)] was negligible [0.01 (−0.03 to 0.05)],
and paths e23 and e24 could be constrained to zero
without a signiﬁcant decrement in ﬁt (see online
Supplementary material). Therefore, CON explained
the covariation between MDD and AUD solely via
genetic mechanisms: a moderate proportion of the gen-
etic covariance was explained by genetic inﬂuences on
CON (0.32; see Table 4). In this model, genetic
inﬂuences both speciﬁc to and shared between CON
and SR accounted for 66% of the genetic covariation
[A = 0.66 (0.38–0.94)], and unique environmental
inﬂuences explained 20% of the unique environmental
covariation [E = 0.20 (0.03–0.38)].
We subsequently ﬁt a model in which CON was
entered ﬁrst. Results indicated that both genetic and
environmental inﬂuences unique to SR accounted for
a signiﬁcant proportion of the genetic (0.33) and envir-
onmental (0.23) covariance between MDD and AUD
(Table 4). In this model, 71% of the genetic and 23%
of the unique environmental covariation between
AUD and MDD was explained by both CON and SR
[A = 0.71 (0.42–0.995), E = 0.23 (0.04–0.41)].
Discussion
The current study investigated whether transdiagnos-
tic factors, negative emotionality and behavioral
Table 2. Within-trait and cross-trait twin correlations between major depressive disorder, alcohol use disorder, stress reaction, and control
Twin 2 phenotype
Monozygotic men (500 pairs) Monozygotic women (671 pairs)
Twin 1 phenotype 1 2 3 4 1 2 3 4
1. Major depressive disorder 0.34 0.43
2. Alcohol use disorder 0.19 0.52 0.25 0.53
3. Stress reaction 0.25 0.15 0.44 0.24 0.11 0.43
4. Behavioral control 0.19 0.22 0.09 0.43 0.10 0.26 −0.02 0.36
Dizygotic men (443 pairs) Dizygotic women (548 pairs)
Twin 1 phenotype 1 2 3 4 1 2 3 4
1. Major depressive disorder −0.01 0.30
2. Alcohol use disorder −0.01 0.28 0.06 0.26
3. Stress reaction −0.09 0.07 0.08 0.15 0.01 0.19
4. Behavioral control 0.004 0.15 −0.01 0.16 0.04 0.16 −0.05 0.20
There were also 701 twins from incomplete pairs (153 monozygotic men, 151 monozygotic women, 216 dizygotic men, 181
dizygotic women).
6 J. M. Ellingson et al.
http:/www.cambridge.org/core/terms. http://dx.doi.org/10.1017/S0033291716001525
Downloaded from http:/www.cambridge.org/core. Washington University St. Louis, on 04 Sep 2016 at 21:06:39, subject to the Cambridge Core terms of use, available at
control, account for the covariation between MDD and
AUD. Consistent with prior work, results suggest that
both risk factors account for a statistically signiﬁcant
proportion of the covariation between MDD and
AUD (Ellingson et al. 2015). Further, nearly all of the
covariation explained by control was due to genetic
factors, and negative emotionality explained the co-
variation via genetic and environmental factors.
These ﬁndings are of particular interest with regard
to NIMH’s RDoC initiative, which involves ‘shifting
the central research focus of the ﬁeld away from clinic-
al description to more squarely examine aberrant
mechanisms. RDoC ﬁrst aims to identify reliable and
valid psychological and biological mechanisms and
their disruptions, with an eventual goal of understand-
ing how anomalies in these mechanisms drive psychi-
atric symptoms’ (p. 631, Sanislow et al. 2010). As
outlined by the RDoC proposal, the trait measures of
negative emotionality and behavioral control used in
the current study map onto the negative valence (e.g.
potential threat) and cognitive (e.g. cognitive/effortful
control) systems, respectively (Morris & Cuthbert,
2012).
The extant literature suggests that negative emotion-
ality may increase risk for MDD and other internaliz-
ing psychopathology, as distress and negative affect
Table 3. Bivariate behavior genetic model estimates of the proportion of covariation for psychiatric diagnoses [major depressive disorder
(MDD), alcohol use disorder (AUD)] and personality measures (behavioral control, stress reactivity) attributed to genetic and environmental
factors, and genetic and environmental correlation estimates
Phenotype
Proportion of covariation due to biometric factors
Behavioral control and diagnosis Stress reactivity and diagnosis
Additive genetic Unique environment Additive genetic Unique environment
Full sample
DSM-5 AUD 0.96 (0.92–0.99 ) 0.04 (0.01 to 0.08) 0.56 (0.30–0.82) 0.44 (0.18–0.70)
DSM-5 MDD 0.83 (0.73–0.93) 0.17 (0.07 to 0.27) 0.59 (0.45–0.73) 0.41 (0.27–0.55)
Men
DSM-5 AUD 0.93 (0.84–1.00) 0.08 (−0.01 to 0.16) 0.63 (0.26–1.00) 0.37 (0.00–0.74)
DSM-5 MDD 0.77 (0.61–0.93) 0.23 (0.07 to 0.39) 0.50 (0.26–0.75) 0.50 (0.26–0.74)
Women
DSM-5 AUD 0.96 (0.93–1.00) 0.04 (−0.002 to 0.08) 0.49 (0.12–0.86) 0.51 (0.14–0.88)
DSM-5 MDD 0.86 (0.73–0.99) 0.14 (0.01 to 0.27) 0.64 (0.47–0.82) 0.36 (0.18–0.53)
Phenotype
Biometric factor correlations
Behavioral control and diagnosis Stress reactivity and diagnosis
rG rE rG rE
Full sample
DSM-5 AUD 0.57 (0.44–0.69) −0.01 (−0.11 to 0.10) 0.26 (0.13–0.39) 0.18 (0.08–0.29)
DSM-5 MDD 0.32 (0.17–0.47) −0.03 (−0.12 to 0.07) 0.56 (0.44–0.69) 0.27 (0.18–0.36)
Men
DSM-5 AUD 0.48 (0.29–0.68) −0.01 (−0.18 to 0.15) 0.32 (0.12–0.52) 0.16 (0.00–0.32)
DSM-5 MDD 0.48 (0.22–0.75) −0.04 (−0.18 to 0.10) 0.58 (0.32–0.83) 0.30 (0.16–0.45)
Women
DSM-5 AUD 0.62 (0.44–0.79) 0.00 (−0.14 to 0.14) 0.21 (0.04–0.38) 0.20 (0.06–0.34)
DSM-5 MDD 0.24 (0.05–0.43) −0.02 (−0.15 to 0.10) 0.57 (0.43–0.71) 0.24 (0.13–0.35)
AUD, Alcohol use disorder; MDD, major depressive disorder.
Values in parentheses are 95% conﬁdence intervals. Some conﬁdence intervals exceeded possible values and were bounded
at 1.00.
Not shown are model estimates for the proportion of covariation between AUD-MDD [A = 0.63 (0.41–0.85), E = 0.37 (0.15–0.59)],
and the biometrical factor correlations among AUD and MDD [full sample: rG = 0.44 (0.28–0.60), rE = 0.22 (0.09–0.36); men: rG = 0.40
(0.11–0.68), rE = 0.31 (0.11–0.50); and women: rG = 0.47 (0.28–0.66), rE = 0.15 (−0.03 to 0.34)].
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are central to these disorders (Clark & Watson, 1991;
Eaton et al. 2011). In contrast, evidence suggests that
negative emotionality increases risk for AUD by way
of coping motives and alcohol use as a means of affect
regulation (Cooper et al. 1995), which may then in-
crease liability for alcohol-related consequences.
Supporting this relation, longitudinal research has
found that changes in coping-related drinking motives
mediate the association between changes in neuroti-
cism and alcohol-related problems (Littleﬁeld et al.
2010), and genetically-informed research has shown
that coping-related drinking motives mediate the gen-
etic overlap between neuroticism and alcohol-related
problems (Littleﬁeld et al. 2011).
With respect to behavioral control, measures such as
disinhibition have been linked with AUD and other ex-
ternalizing psychopathology, as these disorders are
characterized by impulsive behavior (Gorenstein &
Newman, 1980; Sher & Trull, 1994). There has been con-
siderably less work concerning behavioral control as a
risk factor for MDD and other internalizing disorders,
but a lack of self-control has been linked to general,
negative outcomes (e.g. health behaviors, mortality;
Bogg & Roberts, 2004). There are several processes by
which control-based risk may underlie MDD and
AUD. Prior work by our group found that the
Effortful Control Scale (subscales of inhibitory control,
activational control, attentional control; Derryberry &
Rothbart, 1988) explained a substantial proportion of
the covariation between MDD and AUD (Ellingson
et al. 2015). Given the content of the Effortful Control
and MPQ Control scales, low behavioral control may
be a risk mechanism via diminished ability to inhibit
urges to drink, thus increasing liability for AUD
(Sharbanee et al. 2014). Similarly, low behavioral control
may decrease one’s tendency to initiate adaptive activ-
ities when a depressed mood is present, thus increasing
liability for MDD (Dimidjian et al. 2011). Alternatively,
cognitive/attentional control may increase attentional
biases toward stimuli high in emotional valence, such
as ﬁxations on potential reward (e.g. craving; Field
et al. 2006) or loss/threat (e.g. rumination; Ouimet
et al. 2009). Finally, behavioral control may confer risk
broadly via maladaptive decision making, resulting in
problematic alcohol use, as well as negative life circum-
stances that make depressive episodes more likely. It
will be important for future research to elucidate how
control-based processes are associated with MDD and
AUD, and potentially general psychopathology (Caspi
et al. 2013).
These ﬁndings do not identify speciﬁc genetic or en-
vironmental factors related to SR or CON that contrib-
ute to MDD and AUD. Molecular genetic research is
needed to further the progress in this area. Notably,
the RDoC proposal suggests that transdiagnostic risk
factors, such as the negative valence and control sys-
tems, are more likely to map onto the biological
systems that drive psychopathology. That being said,
the search for genetic markers of personality traits
has not yet yielded robust ﬁndings, and the current
understanding is that any genes identiﬁed will be
of extremely small effect and require very large sam-
ples to be discovered (e.g. Genetics of Personality
Consortium et al. 2015, n > 50 000, 100 + signiﬁcant
genetic associations; Schizophrenia Working Group
of the Psychiatric Genomics Consortium et al. 2014).
Notably, de Moor et al. (2015) used polygenic risk
scores (i.e. a composite of the top risk alleles) to explain
1% of the variance in neuroticism from the top
markers via meta-analysis of 27 studies and over
63 000 participants.
The twin correlations in the current study also sug-
gest potential sex differences in how behavioral control
and negative emotionality confer risk for psychopath-
ology. In particular, there was a notable difference in
DZ correlations involving MDD for men and women,
but MZ correlations were similar for men and
women. Future research may beneﬁt from including
opposite-sex twin pairs to investigate whether quanti-
tative or qualitative sex differences confer risk for psy-
chopathology via behavioral control and negative
emotionality (Neale & Maes, 1999; Neale et al. 2006).
Limitations
There are at least three limitations that should be con-
sidered when interpreting the ﬁndings of the current
Table 4. Proportions of the genetic and environmental covariation
between major depressive disorder and alcohol use disorder
accounted for by genetic and environmental inﬂuences speciﬁc to









Stress reaction 0.33 (0.14–0.52) 0.23 (0.04 to 0.41)
Behavioral control 0.32 (0.16–0.48) 0.00 (0.00 to 0.00)
Men
Stress reaction 0.46 (0.05–0.87) 0.17 (−0.04 to 0.37)
Behavioral control 0.42 (0.08–0.77) 0.00 (0.00 to 0.00)
Women
Stress reaction 0.26 (0.03–0.48) 0.32 (−0.11 to 0.74)
Behavioral control 0.26 (0.07–0.45) 0.00 (0.00 to 0.00)
Values in parentheses are 95% conﬁdence intervals.
The proportion of environmental covariance explained by
environmental inﬂuences on Control was negligible (0.01)
and was constrained to 0.00 for model-ﬁtting.
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study. Given that the sample was a cohort of middle-
aged Australian adults, the results may not generalize
to other ages or samples, particularly those with differ-
ent degrees of risk for alcohol or mood-related pro-
blems (e.g. adolescence, emerging adulthood). In
addition, self-report measures of personality were
used. Much of the work on ‘bottom-up’ emotional
reactivity and ‘top-down’ cognitive control uses la-
boratory-based measures and/or neuroimaging
methods. Applying these alternative measurement
methods to similar cognitive and affective factors will
be important for understanding how these factors
confer risk for both MDD and AUD. Regarding the ap-
plication of these ﬁndings to constructs described in
RDoCs, the use of categorical diagnoses rather than
symptom counts may be viewed as a limitation.
These concerns may be allayed by the analytic ap-
proach, however, which assumes that the distributions
of liability for MDD and AUD are continuous and nor-
mal, and diagnoses represent cases in which liability
crosses a threshold (i.e. liability-threshold model;
Neale & Cardon, 1992). Finally, and as noted above,
the current analytic approach allows important infer-
ences to be made about the aggregate genetic liability
to these disorders, but molecular genetic research
will be important for identifying speciﬁc genes that
contribute to the risk for internalizing and externaliz-
ing psychopathology related to cognitive and negative
valence systems. In addition, the cross-twin, cross-trait
correlations in the current study suggest the presence
of non-additive genetic inﬂuences (i.e. dominance or
epistasis), with MZ twin estimates more than twice
that of DZ twin estimates. The current sample was
underpowered to adequately investigate these possibil-
ities, but future behavior and molecular genetic studies
could address this possibility.
Conclusions
The current study shows that trait measures of behav-
ioral control account for the covariation between MDD
and AUD (Li & Sinha, 2008; Field et al. 2010; Kanske &
Kotz, 2012; Ellingson et al. 2015) beyond what is
accounted for by negative emotionality (Khan et al.
2005). Importantly, this is the ﬁrst study to demon-
strate that both behavioral control and negative emo-
tionality confer risk for this covariation via genetic
factors, and that negative emotionality also confers
risk for this covariation via environmental factors.
Given the distinct role that behavioral control appears
to play in the covariation between these two distinct
disorders, future research could investigate whether
behavioral control underlies risk for general psycho-
pathology, as has been shown for negative emotional-
ity (Tackett et al. 2013). Additional research will also be
needed for identifying speciﬁc risk factors that com-
prise this genetic and environmental risk. In addition,
longitudinal research will be important for disentan-
gling the temporal relation between MDD, AUD, be-
havioral control, and negative emotionality. Finally,
these ﬁndings suggest that behavioral control and
negative emotionality may be important intervention
targets to address a wide range of mental health
problems.
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1 These correlations were estimated in Mplus. They differ
slightly from the correlations presented in Table 1 as full
information maximum likelihood procedures were
employed to account for missing data.
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